South Korea, Japan and Taiwan rush to develop homegrown vaccines

Sluggish vaccination rollouts make the three places vulnerable to outbreaks

20210525 SK Vaccine

South Korean President Moon Jae-in inspects a vaccine vial at an SK Bioscience plant in the city of Andong on Jan. 20. His government has come under fire over a slow vaccine rollout. (Source photos by Reuters and EPA/Yonhap/Jiji)

KIM JAEWON, MITSURU OBE and LAULY LI, Nikkei staff writers

SEOUL/TOKYO/TAIPEI -- Chang Hyo-jung, a senior nurse at a general hospital in New York, is considering going back to her home country of South Korea in October for a four-week vacation. But it is unclear whether she will be able to avoid a two-week quarantine on arrival, even though she has been fully vaccinated with two Pfizer shots in the U.S.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.